Literature DB >> 12719633

Upper and lower face and ideomotor apraxia in patients with Alzheimer's disease.

Jay Guido Capone1, Sergio Della Sala, Hans Spinnler, Annalena Venneri.   

Abstract

INTRODUCTION: Apraxia of face movement in Alzheimer's disease (AD) has been rarely investigated. This study aimed at investigating the frequency of lower (mouth, tongue and throat) and upper (eyes and eyebrows) face apraxia, in AD and its relationship with limb apraxia and severity of dementia.
METHODS: Fifty seven patients with AD were tested with a new standardised test of face apraxia including upper and lower face movements, which uses an item-difficulty weighted scoring procedure, the IMA test, a test of ideomotor apraxia and the M.O.D.A., a means to assess dementia severity.
RESULTS: Thirteen (23%) and 19 (33%) participants were below cut-off respectively on the upper and lower face apraxia test. Both sections of the Face Apraxia Test correlated significantly with the Ideomotor Apraxia Test. However, double dissociations between different types of apraxia were observed. Both the upper and lower face apraxia tests correlated significantly with the measure of dementia severity.
CONCLUSIONS: The finding show that a proportion of AD patients fails face apraxia tests. Their face apraxia is interlinked with ideomotor limb apraxia, although dissociations are possible. Severity of dementia deterioration accounts for a good proportion of the variability of AD patients' performance on face apraxia tests.

Entities:  

Mesh:

Year:  2003        PMID: 12719633      PMCID: PMC5497562          DOI: 10.1155/2003/518959

Source DB:  PubMed          Journal:  Behav Neurol        ISSN: 0953-4180            Impact factor:   3.342


  2 in total

1.  Walking difficulties in patients with Alzheimer's disease might originate from gait apraxia.

Authors:  S Della Sala; H Spinnler; A Venneri
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

2.  Apraxia for differentiating Alzheimer's disease from subcortical vascular dementia and mild cognitive impairment.

Authors:  Serhat Ozkan; Demet Ozbabalik Adapinar; Nese Tuncer Elmaci; Didem Arslantas
Journal:  Neuropsychiatr Dis Treat       Date:  2013-07-09       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.